Clinical Trials Sponsored by AGO Germany

Total 6298 results

Merck KGaA, Darmstadt, Germany

Completed

A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood

Growth Hormone Deficiency | Dwarfism
Merck KGaA, Darmstadt, Germany

Withdrawn

A Post-marketing Surveillance Study on Erbitux in Combination With Platinum-based Chemotherapy in Metastatic/Recurrent Squamous Cell Cancer of the Head and Neck

Neoplasms, Squamous Cell
Merck KGaA, Darmstadt, Germany

Completed

Study to Evaluate the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab. (FUTURE)

Previously Untreated Metastatic Colorectal Cancer

France, Italy, Poland, Germany, Hong Kong, Austria, Brazil, Israel, Greece, Argentina, Thailand, Belgium, Australia, Mexico
Merck KGaA, Darmstadt, Germany

Completed

Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX) (FLEX)

Non Small Cell Lung Cancer (NSCLC)

Sweden, Australia, Brazil, Bulgaria, Czech Republic, France, Italy, Korea, Republic of, Mexico, Russian Federation, Spain, Turkey, United Kingdom, Germany, Poland, Ukraine, Argentina, Austria, Hungary, Netherlands, Slovakia, Taiwan, Chil... and more
Merck KGaA, Darmstadt, Germany

Completed

EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC)

Lung Cancer | Non Small Cell Lung Cancer

Netherlands
Merck KGaA, Darmstadt, Germany

Completed

Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) (ADVANTAGE)

Squamous Cell Cancer

France, Italy, Spain, Germany, Hungary, Austria, Switzerland, Belgium, Poland
Merck KGaA, Darmstadt, Germany

Completed

Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Squamous Cell Carcinoma of the Head and Neck

Japan
Merck KGaA, Darmstadt, Germany

Completed

A Canadian Study Assessing the Utility of the Treatment Optimization Recommendations in Multiple Sclerosis (CanTOR)

Multiple Sclerosis, Relapsing-Remitting
Merck KGaA, Darmstadt, Germany

Completed

An Observational Study of Multiple Sclerosis (MS) Patients Starting or Restarting Baseline Treatment With Interferon Beta 1a After the Use of Escalation Treatment With Mitoxantrone (RETURN)

Relapsing-Remitting Multiple Sclerosis
Merck KGaA, Darmstadt, Germany

Completed

Metabolic Endocrinology and Growth Hormone in Adults (MEGHA FRANCE)

Adult Growth Hormone Deficiency
Merck KGaA, Darmstadt, Germany

Terminated

TRUST Study: Raptiva ® in Hand & Foot Psoriasis (TRUST)

Chronic Plaque Psoriasis

Austria
Merck KGaA, Darmstadt, Germany

Completed

Study of Therapeutic Options for Subjects Discontinuing Efalizumab and Experiencing Disease Recurrence

Psoriasis
Merck KGaA, Darmstadt, Germany

Completed

Study To Evaluate The Immunogenicity And Safety Of r-hIFN Beta-1a (Rebif®) Using Clone 484-39 In Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis
Merck KGaA, Darmstadt, Germany

Completed

EMD 640 744 in Montanide ISA 51 VG Administered in Subjects With Advanced Solid Tumors

Advanced Solid Tumors
Merck KGaA, Darmstadt, Germany

Completed

An Observational Study to Examine the Patients With Isolated Systolic Hypertonia (ISH) Under Therapy With Eneas® (NIS ENEAS ISH)

Hypertension
Merck KGaA, Darmstadt, Germany

Completed

Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer

Gastric Cancer | Esophageal Cancer

United Kingdom
Merck KGaA, Darmstadt, Germany

Completed

Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART)

Infertility

United States
Merck KGaA, Darmstadt, Germany

Terminated

AS900672-Enriched in Ovulation Induction

Ovulation Induction

Switzerland
Merck KGaA, Darmstadt, Germany

Completed

Pharmacokinetics in Subjects With Renal Impairment

Renal Impairment

Germany
Merck KGaA, Darmstadt, Germany

Completed

Observational Study With Prospective and/or Retrospective Follow-up, Without Modifying Patient Treatment and Follow-up Practices for the Initial Treatment of Hypothyroidism in France (ORCHIDEE)

Hypothyroidism

France
Merck KGaA, Darmstadt, Germany

Completed

AS703569 and Gemcitabine Combination in Advanced Malignancies

Pancreatic Cancer

Belgium, France
Charite University, Berlin, Germany

Unknown

Risk Stratification and Goal-directed Volume Therapy

Fluid Volume Disorder

Germany
Merck KGaA, Darmstadt, Germany

Terminated

Minocycline as add-on to Interferon Beta-1a [IFN Beta-1a] (Rebif®) in Relapsing-Remitting Multiple Sclerosis [RRMS] (RECYCLINE)

Multiple Sclerosis, Relapsing-Remitting

Denmark
Charite University, Berlin, Germany

Unknown

Outcome After Descemet Membrane Endothelial Keratoplasty (DMEK) and Ultra-thin Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)

Endothelial Dysfunction | Bullous Keratopathy | Fuchs' Endothelial Corneal Dystrophy | Iridocorneal Endothelial Syndrome | Posterior Polymorphous Dystrophy

Germany
Merck KGaA, Darmstadt, Germany

Completed

To Assess the Prevalence of Spasticity and the Impact on the Quality of Life in Multiple Sclerosis Patients

Multiple Sclerosis, Relapsing Remitting

Argentina
Charite University, Berlin, Germany

Completed

Prevalence of Cachexia in Patients Undergoing Chemotherapy

Cancer | Cachexia

Germany
Charite University, Berlin, Germany

Completed

Validation of Stroke Volume Measurement by a New Noninvasive Hemodynamic Monitoring System (NexFin)in Comparison to Different Invasive Procedures as Picco2, FloTrac and TEE (VaSNex)

Stroke Volume | Mean Arterial Pressure

Germany
Charite University, Berlin, Germany

Completed

Neonates With Very Low Birth Weight and Surgery Therapy of Acute Abdomen (NeoNec)

Very Low Birth Weight

Germany
Charite University, Berlin, Germany

Unknown

Zevalin® First Line in Follicular Lymphoma

Follicular Lymphoma
Charite University, Berlin, Germany

Unknown

Influence of Surgical Regional Anesthesia on Postoperative Pain (CESAR)

Elective Cesarean Section

Germany
Charite University, Berlin, Germany

Completed

Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia

Androgenetic Alopecia | Female Pattern Hair Loss

Germany
Charite University, Berlin, Germany

Terminated

Effect of Saliva Substitutes on Dental Hard Tissues in Situ (T-01)

Hyposalivation

Germany
Charite University, Berlin, Germany

Completed

Low Grade Inflammation, Gut Microbiota and Barrier Function in Elderly Humans

Healthy | Aged

Germany
Charite University, Berlin, Germany

Terminated

Sequential Treatment of CD20-positive Posttransplant Lymphoproliferative Disorder (PTLD)

Post-transplantation Lymphoproliferative Disorder

Australia, France, Germany, Sweden
Charite University, Berlin, Germany

Completed

Evaluation of a Touchless Vein Scanner for Venepuncture and Cannulation in Pediatric Patients (VENSCAN)

Venepuncture

Germany
Charite University, Berlin, Germany

Completed

An Algorithm for Intra-operative Goal-directed Haemodynamic Management in Non-cardiac Surgery (ERAS_feasi)

Fracture of Surgical Neck of Humerus | Colonic Tumor | Stage IIIB Ovarian Carcinoma | Neoplasm of Head of Pancreas

Germany
Charite University, Berlin, Germany

Completed

320-slice Coronary Computed Tomography (CT) Angiography

Coronary Artery Stenosis

Germany
Charite University, Berlin, Germany

Completed

Transcranial Galvanic Stimulation After Stroke (TraGAT)

Stroke

Germany, Italy
Charite University, Berlin, Germany

Completed

Advance Directives and End-of-life Decision Making in Intensive Care Medicine in Germany

Death

Germany
Charite University, Berlin, Germany

Unknown

Endothelial Function and Progenitor Cells in Acute Ischemic Stroke (EPCAS)

Ischemic Stroke

Germany
Charite University, Berlin, Germany

Completed

Prevalence of Malnutrition in Oncologic Patients

Cancer | Malnutrition

Germany
Charite University, Berlin, Germany

Completed

Malnutrition in Gastroenterology Patients

Malnutrition

Germany
Charite University, Berlin, Germany

Completed

Urine NT-proBNP Levels and Echocardiographic Findings in Very Low Birth Weight (VLBW) Infants

Ductus Arteriosus, Patent | Infant, Premature | Ventricular Function, Left

Germany
Charite University, Berlin, Germany

Unknown

Exercise for Patients With HIV Infections

HIV Infections | Inflammation | Lipodystrophy

Germany
Charite University, Berlin, Germany

Completed

Immunomodulation of E.Coli Nissle 1917 in Patients With Grass Pollen Rhinoconjunctivitis (Ecorhino)

Rhinoconjunctivitis

Germany
Charite University, Berlin, Germany

Unknown

Long Time Metabolic Changes Induced by Genetically Modified Potatoes

Glucose Metabolism | Satiety | Hormonal Changes

Germany
Charite University, Berlin, Germany

Unknown

Deep Brain Stimulation (DBS) For Parkinson's Disease: Caudal Zona Incerta Versus Subthalamic Nucleus

Parkinson's Disease

Germany
Charite University, Berlin, Germany

Completed

Tryptophan Metabolism in Kidney Disease

Chronic Kidney Disease

Germany
Charite University, Berlin, Germany

Completed

Morphometric, Clinical and Histological Study on One Stage Bone Augmentation Using BoneCeramic (BCP) and Collagen Membranes (BCP+Collagen)

Dehiscent Type of Alveolar Bone Defect | One Stage Bone Augmentation
Charite University, Berlin, Germany

Unknown

Neurobiological, Neuropsychological,Linguistic and Gestural Processes and Phenomena in Individuals With Alexithymia (ALEX)

Alexithymia

Germany

Clinical Trials Sponsored by AGO Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations